Prices are updated after-hours


Sort by: after hours percent change | delayed percent change | gain open | gain high | gain close | publishing date

symbols : XENE    save search

Xenon Pharmaceuticals Announces Closing of $287.5 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2022-06-27 (Crawled : 19:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.51% C: -4.29%

offering
Xenon Pharmaceuticals Announces Pricing of $250.0 Million Public Offering
Published: 2022-06-23 (Crawled : 03:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: -8.15% H: 5.85% C: 3.59%

offering
Xenon Pharmaceuticals Provides Update on Additional Positive Data from the XEN1101 Program
Published: 2022-06-22 (Crawled : 21:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 7.12% H: 0.0% C: 0.0%

xen1101 program positive update
Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA
Published: 2022-06-21 (Crawled : 12:20) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 8.06% H: 0.0% C: 0.0%

fda meeting positive
Xenon Pharmaceuticals to Present at the 2022 Jefferies Healthcare Conference
Published: 2022-06-01 (Crawled : 22:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 0.57% H: 1.81% C: 0.68%

conference
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss First Quarter 2022 Financial Results and Provide Corporate Update
Published: 2022-05-03 (Crawled : 00:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 0.0% C: 0.0%

conference results
Xenon Pharmaceuticals Announces Initiation of Phase 2 Clinical Trial to Evaluate XEN1101 as a Treatment for Major Depressive Disorder (MDD)
Published: 2022-05-03 (Crawled : 19:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: -0.22% H: 0.0% C: 0.0%

xen1101 treatment for trial
Xenon Pharmaceuticals to Present at the 21st Annual Needham Virtual Healthcare Conference
Published: 2022-04-04 (Crawled : 22:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 1.11% H: 4.55% C: 4.37%

conference
Xenon Pharmaceuticals Reports 2021 Financial Results and Provides Corporate Update
Published: 2022-03-01 (Crawled : 23:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: -9.48% H: 16.24% C: 13.88%

als financial results report results
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Year-End 2021 Financial Results and Provide Corporate Update
Published: 2022-02-22 (Crawled : 22:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 1.23% H: 3.1% C: -10.88%

als financial results conference results
Xenon Pharmaceuticals to Participate in the 11th Annual SVB Leerink Global Healthcare Conference
Published: 2022-02-14 (Crawled : 23:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 0.72% H: 1.88% C: -0.58%

health als thc conference svb leerink global
Expansion Therapeutics Appoints Gary Bridger, Ph.D., to Its Board of Directors
Published: 2022-01-19 (Crawled : 13:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: -0.8% H: 6.48% C: 1.93%

expansion therapeutics
Xenon Pharmaceuticals Announces Collaboration with Neurocrine Biosciences Achieves $15.0 Million Regulatory Milestone
Published: 2022-01-12 (Crawled : 14:00) - biospace.com/
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 3.38% H: 0.31% C: -4.18%
NBIX S | $99.19 1.75% -0.48% | twitter stocktwits trandingview |
Health Technology
| | O: -0.79% H: 3.15% C: 1.82%

milestone bioscience collaboration
Xenon Pharmaceuticals Presents Additional Positive Data from Phase 2b ‘X-TOLE’ Clinical Trial at the Annual Meeting of the American Epilepsy Society (AES 2021)
Published: 2021-12-03 (Crawled : 12:30) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 1.77% H: 0.0% C: 0.0%

phase 2 phase 2b trial positive
Xenon Pharmaceuticals Provides Updates on Proprietary Neurology Pipeline Programs at the Annual Meeting of the American Epilepsy Society (AES 2021)
Published: 2021-12-03 (Crawled : 12:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 1.77% H: 0.0% C: 0.0%


Xenon Pharmaceuticals to Participate in Upcoming Investor Conferences
Published: 2021-11-12 (Crawled : 14:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: -7.25% H: 0.0% C: 0.0%

conference
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Third Quarter 2021 Financial Results and Provide Corporate Update
Published: 2021-11-03 (Crawled : 20:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: -0.26% H: 6.88% C: 2.26%

financial results results conference
Xenon Pharmaceuticals Announces Closing of $345 Million Public Offering Including Full Exercise of the Underwriters’ Option to Purchase Additional Shares
Published: 2021-10-08 (Crawled : 19:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

offering
Xenon Pharmaceuticals Announces Pricing of $300.0 Million Public Offering
Published: 2021-10-06 (Crawled : 02:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 4.2% H: 7.62% C: 2.5%

offering publication
Xenon Pharmaceuticals Announces Conference Call and Webcast to Discuss Topline Results from Phase 2b ‘X-TOLE’ Clinical Trial of XEN1101
Published: 2021-10-03 (Crawled : 00:00) - globenewswire.com
XENE A 4 d | $30.77 1.15% -2.86% | twitter stocktwits trandingview |
Health Technology
| | O: 69.5% H: 22.03% C: 18.82%

phase 2 results topline phase 2b trial conference

USA Holiday (Independence Day) in 2 days

Your saved searches
Save your searches and get alerts when important news are released.

Mentioned Today
APPN | News 4 | $47.15 -0.44% 4.22% | twitter stocktwits trandingview |
Technology Services

ARQQ | News | $6.2 -1.74% -2.54% | twitter stocktwits trandingview |
Information

CDNA | News | $22.38 4.19% 0.0% | twitter stocktwits trandingview |
Health Technology

FNCTF | News | $11.99 | twitter stocktwits trandingview |
Communications

HLF | News | $21.56 5.43% 0.0% | twitter stocktwits trandingview |
Distribution Services

HYB | News | $9.16 0% | twitter stocktwits trandingview |
Miscellaneous

NVAX | News 4 | $57.11 11.04% 0.91% | twitter stocktwits trandingview |
Health Technology

OKTA | News 4 | $95.96 6.15% -0.61% | twitter stocktwits trandingview |
Technology Services

OSCR | News | $4.57 7.53% 0.0% | twitter stocktwits trandingview |

PEGA | News | $49.44 3.34% 0.0% | twitter stocktwits trandingview |
Technology Services

PM | News 4 | $99.72 0.99% -0.07% | twitter stocktwits trandingview |
Consumer Non-Durables

TDOC | News | $34.83 4.88% -0.4% | twitter stocktwits trandingview |
Health Services

TILE | News | $12.695 1.24% 0.0% | twitter stocktwits trandingview |
Producer Manufacturing

UL | News | $46.29 1.0% -0.02% | twitter stocktwits trandingview |
Consumer Non-Durables

UNLYF | News | $45.67 | twitter stocktwits trandingview |
Consumer Non-Durables